All In Biotech

Drug Trial Radar · NCT03520478

A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer

A Phase III, Multicenter, Randomized, Open Study of SHR3680 Compared to Bicalutamide in the Treatment of Patients With Hormone Sensitive Prostate Cancer

Last checked: Nov 19, 2026Latest source record: Mar 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 654 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

654

Actual

Start

May 30, 2018

Primary completion

Apr 30, 2023

Study completion Apr 30, 2025

Sponsor

Sponsor type
Industry
First posted
May 9, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this study is to compare the safety and efficacy of SHR3680 with bicalutamide in the treatment of patients with hormone sensitive prostate cancer.

Conditions

  • Prostate Cancer
  • Hormone-Dependent Prostate Cancer

Interventions

  • SHR3680Drug

    Tablet. Specifications of 80 mg; orally, once a day

  • BicalutamideDrug

    Tablet. Specifications of 50 mg; orally, once a day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. rPFSTime frame: Approximately 70 months
  2. OSTime frame: Approximately 70 months

Locations

67 sites in 4 countries. Site status is shown where the registry gives one.

  • Complex oncological center - Bourgas

    Burgas, Bulgaria

  • UMHAT 'Deva Maria'. EOOD

    Burgas, Bulgaria

  • MHAT - Dobrich. AD

    Dobrich, Bulgaria

  • MHAT 'Dr. Tota Venkova'. AD

    Gabrovo, Bulgaria

  • Complex Oncological Center - Plovdiv. EOOD

    Plovdiv, Bulgaria

  • MHAT 'Central Onco Hospital'. OOD

    Plovdiv, Bulgaria

  • Acibadem City Clinic Tokuda Hospital Ead

    Sofia, Bulgaria

  • Affiliated Hospital of Hebei University

    Baoding, China

  • Beijing Cancer Hospital

    Beijing, China

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, China

  • Peking Union Medical College Hospital

    Beijing, China

  • The third hospital of Peking University

    Beijing, China

  • Tumor Hospital of the Chinese Academy of Medical Sciences

    Beijing, China

  • China Japan Friendship Hospital of Jilin University

    Changchun, China

  • The first hospital of Jilin University

    Changchun, China

  • Hunan Cancer Hospital

    Changsha, China

  • West China Hospital of Sichuan University

    Chengdu, China

  • Army characteristic medical center of the Chinese people's Liberation Army

    Chongqing, China

  • Chongqing Cancer Hospital

    Chongqing, China

  • The First Affiliated Hospital of Army Medical University

    Chongqing, China

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, China

  • Sun Yat-Sen hospital of Sun Yat-Sen University

    Guangzhou, China

  • Sun Yat-sen University Cancer Center

    Guangzhou, China

  • The First Affiliated Hospital of Zhejiang University Medicine college

    Hangzhou, China

  • The Second affiliated hospital of zhejiang university medical college

    Hangzhou, China

  • Zhejiang Cancer Hospital

    Hangzhou, China

  • Zhejiang Province People's Hospital

    Hangzhou, China

  • Anhui Provincial Hospital

    Hefei, China

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, China

  • Qilu Hospital of Shandong University

    Jinan, China

  • Yunnan Provincial Cancer Hospital

    Kunming, China

  • The second hospital of Lanzhou University

    Lanzhou, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China

  • Gulou Hospital Affiliated to Medical College of Nanjing University

    Nanjing, China

  • Jiangsu Provincial Cancer Hospital

    Nanjing, China

  • Jiangsu Provincial People's Hospital

    Nanjing, China

  • Huadong Hospital of Fudan University

    Shanghai, China

  • Ruijin Hospital

    Shanghai, China

  • Shanghai General Hospital

    Shanghai, China

  • The Cancer Hospital of Fudan University

    Shanghai, China

Showing 40 of 67 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.